242 related articles for article (PubMed ID: 29929108)
1. The adult motor phenotype of Dravet syndrome is associated with mutation of the STXBP1 gene and responds well to cannabidiol treatment.
Álvarez Bravo G; Yusta Izquierdo A
Seizure; 2018 Aug; 60():68-70. PubMed ID: 29929108
[TBL] [Abstract][Full Text] [Related]
2. GABRA1 and STXBP1: novel genetic causes of Dravet syndrome.
Carvill GL; Weckhuysen S; McMahon JM; Hartmann C; Møller RS; Hjalgrim H; Cook J; Geraghty E; O'Roak BJ; Petrou S; Clarke A; Gill D; Sadleir LG; Muhle H; von Spiczak S; Nikanorova M; Hodgson BL; Gazina EV; Suls A; Shendure J; Dibbens LM; De Jonghe P; Helbig I; Berkovic SF; Scheffer IE; Mefford HC
Neurology; 2014 Apr; 82(14):1245-53. PubMed ID: 24623842
[TBL] [Abstract][Full Text] [Related]
3. Clinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations.
Deprez L; Weckhuysen S; Holmgren P; Suls A; Van Dyck T; Goossens D; Del-Favero J; Jansen A; Verhaert K; Lagae L; Jordanova A; Van Coster R; Yendle S; Berkovic SF; Scheffer I; Ceulemans B; De Jonghe P
Neurology; 2010 Sep; 75(13):1159-65. PubMed ID: 20876469
[TBL] [Abstract][Full Text] [Related]
4. Two mild cases of Dravet syndrome with truncating mutation of SCN1A.
Takaori T; Kumakura A; Ishii A; Hirose S; Hata D
Brain Dev; 2017 Jan; 39(1):72-74. PubMed ID: 27544716
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiol for drug-resistant seizures in the Dravet syndrome.
Mellis C
J Paediatr Child Health; 2018 Jan; 54(1):101-102. PubMed ID: 29314377
[No Abstract] [Full Text] [Related]
6. Dravet syndrome: seizure control and gait in adults with different SCN1A mutations.
Rilstone JJ; Coelho FM; Minassian BA; Andrade DM
Epilepsia; 2012 Aug; 53(8):1421-8. PubMed ID: 22780858
[TBL] [Abstract][Full Text] [Related]
7. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.
Devinsky O; Cross JH; Laux L; Marsh E; Miller I; Nabbout R; Scheffer IE; Thiele EA; Wright S;
N Engl J Med; 2017 May; 376(21):2011-2020. PubMed ID: 28538134
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome.
Lattanzi S; Trinka E; Russo E; Striano P; Citraro R; Silvestrini M; Brigo F
Drugs Today (Barc); 2019 Mar; 55(3):177-196. PubMed ID: 30938373
[TBL] [Abstract][Full Text] [Related]
9. Cannabidiol improves survival and behavioural co-morbidities of Dravet syndrome in mice.
Patra PH; Serafeimidou-Pouliou E; Bazelot M; Whalley BJ; Williams CM; McNeish AJ
Br J Pharmacol; 2020 Jun; 177(12):2779-2792. PubMed ID: 32321192
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of antiepileptic drugs for the treatment of Dravet syndrome with different genotypes.
Shi XY; Tomonoh Y; Wang WZ; Ishii A; Higurashi N; Kurahashi H; Kaneko S; Hirose S;
Brain Dev; 2016 Jan; 38(1):40-6. PubMed ID: 26183863
[TBL] [Abstract][Full Text] [Related]
11. Adult motor phenotype differentiates Dravet syndrome from Lennox-Gastaut syndrome and links SCN1A to early onset parkinsonian features.
Aljaafari D; Fasano A; Nascimento FA; Lang AE; Andrade DM
Epilepsia; 2017 Mar; 58(3):e44-e48. PubMed ID: 28186331
[TBL] [Abstract][Full Text] [Related]
12. One novel Dravet syndrome causing mutation and one recurrent MAE causing mutation in SCN1A gene.
Yordanova I; Todorov T; Dimova P; Hristova D; Tincheva R; Litvinenko I; Yotovska O; Kremensky I; Todorova A
Neurosci Lett; 2011 Apr; 494(2):180-3. PubMed ID: 21396429
[TBL] [Abstract][Full Text] [Related]
13. Stiripentol (Diacomit) for Dravet syndrome.
Med Lett Drugs Ther; 2021 Mar; 63(1620):e48-e50. PubMed ID: 33976090
[No Abstract] [Full Text] [Related]
14. Epileptic patients with de novo STXBP1 mutations: Key clinical features based on 24 cases.
Di Meglio C; Lesca G; Villeneuve N; Lacoste C; Abidi A; Cacciagli P; Altuzarra C; Roubertie A; Afenjar A; Renaldo-Robin F; Isidor B; Gautier A; Husson M; Cances C; Metreau J; Laroche C; Chouchane M; Ville D; Marignier S; Rougeot C; Lebrun M; de Saint Martin A; Perez A; Riquet A; Badens C; Missirian C; Philip N; Chabrol B; Villard L; Milh M
Epilepsia; 2015 Dec; 56(12):1931-40. PubMed ID: 26514728
[TBL] [Abstract][Full Text] [Related]
15. Bromide in patients with SCN1A-mutations manifesting as Dravet syndrome.
Lotte J; Haberlandt E; Neubauer B; Staudt M; Kluger GJ
Neuropediatrics; 2012 Feb; 43(1):17-21. PubMed ID: 22430156
[TBL] [Abstract][Full Text] [Related]
16. Comment: Dravet syndrome--"old gene," novel mechanism.
Xu M
Neurology; 2014 Apr; 82(14):1250. PubMed ID: 24623837
[TBL] [Abstract][Full Text] [Related]
17. SCN1A mutation screening in adult patients with Lennox-Gastaut syndrome features.
Selmer KK; Lund C; Brandal K; Undlien DE; Brodtkorb E
Epilepsy Behav; 2009 Nov; 16(3):555-7. PubMed ID: 19782004
[TBL] [Abstract][Full Text] [Related]
18. Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations.
Milh M; Villeneuve N; Chouchane M; Kaminska A; Laroche C; Barthez MA; Gitiaux C; Bartoli C; Borges-Correia A; Cacciagli P; Mignon-Ravix C; Cuberos H; Chabrol B; Villard L
Epilepsia; 2011 Oct; 52(10):1828-34. PubMed ID: 21770924
[TBL] [Abstract][Full Text] [Related]
19. Dravet syndrome: from electroclinical characteristics to molecular biology.
Arzimanoglou A
Epilepsia; 2009 Sep; 50 Suppl 8():3-9. PubMed ID: 19702726
[TBL] [Abstract][Full Text] [Related]
20. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA
PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
